Accessibility StatementSkip Navigation LOS ANGELES, Sept. 25, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against V.F. Corporation ("VF " or "the Company") (NYSE: VFC ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.  WHY DJS LAW GROUP? DJS Law Group's primary focus is to enhance investor return through balanced counseling and aggressive advocacy. We specia ...

Accessibility StatementSkip Navigation Join the case to recover your losses. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics. LOS ANGELES, Sept. 25, 2025 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Quanex Building Products Corporation ("Quanex " or "the Company") (NYSE: NX ) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by t ...

Accessibility StatementSkip Navigation WHY DJS LAW GROUP? DJS Law Group's primary focus is to enhance investor return through balanced counseling and aggressive advocacy. We specialize in securities class actions, corporate governance litigation, and domestic/international M&A appraisals. Our clients are some of the largest and most sophisticated hedge funds and alternative asset managers in the world. The litigation claims of our clients are extraordinarily valuable assets that demand respect, focus, and ...

Accessibility StatementSkip Navigation WHY DJS LAW GROUP? Â DJS Law Group's primary focus is to enhance investor return through balanced counseling and aggressive advocacy. We specialize in securities class actions, corporate governance litigation, and domestic/international M&A appraisals. Our clients are some of the largest and most sophisticated hedge funds and alternative asset managers in the world. The litigation claims of our clients are extraordinarily valuable assets that demand respect, focus, and ...

Accessibility StatementSkip Navigation NEW YORK, Sept. 25, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Fly-E Group, Inc. (NASDAQ: FLYE). Shareholders who purchased shares of FLYE during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.` CONTACT US HERE: SOURCE The Gross Law Firm WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+N ...

公司相关法律事件 - Gross Law Firm向Savara Inc (NASDAQ: SVRA)股东发布集体诉讼通知 涉及2024年3月4日至2025年5月23日期间购入股票的投资者[1][3] - 指控内容包括公司对MOLBREEVI BLA的化学制造与控制信息披露不足 FDA不太可能以当前形式批准该药物治疗肺泡蛋白沉积症的申请[3] - 公司被指需额外融资 因MOLBREEVI监管批准延迟可能影响资金状况 此前公开声明被指控存在重大虚假和误导性内容[3] 诉讼程序安排 - 股东参与截止日期为2025年11月7日 需通过指定链接完成登记[4] - 登记股东将接入案件生命周期监控系统 原告代表申请同步截止[4] - 律所提供免费参与通道 不要求必须成为原告代表即可获得赔偿资格[1][4]

诉讼背景 - Gross Law Firm于2025年9月18日向Sable Offshore Corp(纽交所代码SOC)股东发布集体诉讼通知[1] - 诉讼针对在2025年5月19日至6月3日期间购买SOC公开交易证券的个人或实体[1] - 诉讼还涵盖通过公司2025年5月21日二次公开发行购买证券的投资者[1] 指控内容 - 被告被指控在集体诉讼期间发布重大虚假和/或误导性陈述[2] - 公司声称已重启加利福尼亚海岸石油生产但实际并未实施[2] - 被告关于公司业务、运营和前景的陈述缺乏合理依据[2] - 真相披露后导致投资者遭受损失[2] 程序安排 - 股东参与集体诉讼的截止日期为2025年9月26日[3] - 注册股东将加入投资组合监控软件以获取案件进展更新[3] - 申请成为首席原告的截止日期为2025年9月26日[3] - 参与本案无需任何成本或义务[3] 律所信息 - Gross Law Firm是全国公认的集体诉讼律师事务所[4] - 该律所专门保护因欺骗、欺诈和非法商业行为而遭受损失的投资者权利[4] - 致力于确保公司遵守负责任的商业行为并践行良好企业公民责任[4] - 联系地址：纽约西38街15号12楼[5] - 联系电话：(646) 453-8903[5] 相关案例 - Gross Law Firm同时处理Snap Inc(纽交所代码SNAP)投资者集体诉讼案[5][6] - Semler Scientific Inc(纳斯达克代码SMLR)证券违规诉讼截止日期为2025年10月28日[7] - 该律所通过PR Newswire发布多家公司的投资者诉讼通知[5][7]

NEW YORK, Sept. 15, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Novo Nordisk A/S (NYSE: NVO). Shareholders who purchased shares of NVO during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/novo-nordisk-a-s-loss-submission-form-3/?id=166923&from=3 CLASS PERIOD: May 7, 2025 ...

诉讼背景 - Gross Law Firm向Lineage Inc (NASDAQ: LINE)股东发布集体诉讼通知 涉及在2024年7月26日IPO期间购买普通股的投资者[1][3] - 股东参与截止日期为2025年9月30日 无需担任首席原告即可获得赔偿[5] 指控内容 - 公司未披露客户需求持续疲软 因冷链仓储供应增加及客户疫情期间积累的过剩库存正在去化[4] - IPO前实施的价格上涨因需求环境恶化而无法维持[4] - 公司无法通过最低存储保证、运营效率或技术优势抵消不利趋势[4] - 实际出现收入停滞或下降、占用率下降及租金价格下跌 与注册声明中稳定的收入增长和高占用率表述不符[4] - 上述因素导致公司财务业绩、业务运营和前景受到重大损害[4]

核心事件 - 律师事务所代表在2024年10月9日至2025年7月10日期间购买Capricor Therapeutics股票的投资者提起集体诉讼 [2] - 指控公司就治疗杜氏肌营养不良心肌病的主要细胞疗法药物deramiocel向投资者提供重大虚假信息 [2] - 公司声称能够获得FDA生物制剂许可申请 但被指控隐瞒HOPE-2试验四年安全性和有效性数据的不利事实 [2] 监管进展 - 2025年7月11日FDA发出完整回复函 拒绝生物制剂许可申请 [2] - 监管机构指出缺乏有效性实质证据 需要额外临床数据 [2] - 申请文件中化学制造与控制部分存在未解决问题 [2] 市场反应 - 监管拒绝导致股价从2025年7月10日的11.40美元/股暴跌至7月11日的7.64美元/股 单日跌幅达33% [2] - 股价下跌造成投资者重大损失 引发证券集体诉讼 [2][3] 法律程序 - 投资者登记截止日期为2025年9月15日 [3] - 参与投资者将获得案件生命周期内的投资组合监控服务 [3] - 律师事务所专注于保护因欺骗、欺诈和非法商业行为而受损的投资者权利 [4]